skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska

Authors:
; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1397895
Resource Type:
Journal Article: Publisher's Accepted Manuscript
Journal Name:
Harmful Algae
Additional Journal Information:
Journal Volume: 57; Journal Issue: PB; Related Information: CHORUS Timestamp: 2017-10-04 22:38:06; Journal ID: ISSN 1568-9883
Publisher:
Elsevier
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Knaack, Jennifer S., Porter, Kimberly A., Jacob, Justin T., Sullivan, Kate, Forester, Matthew, Wang, Richard Y., Trainer, Vera L., Morton, Steve, Eckert, Ginny, McGahee, Ernest, Thomas, Jerry, McLaughlin, Joseph, and Johnson, Rudolph C. Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. Country unknown/Code not available: N. p., 2016. Web. doi:10.1016/j.hal.2016.03.006.
Knaack, Jennifer S., Porter, Kimberly A., Jacob, Justin T., Sullivan, Kate, Forester, Matthew, Wang, Richard Y., Trainer, Vera L., Morton, Steve, Eckert, Ginny, McGahee, Ernest, Thomas, Jerry, McLaughlin, Joseph, & Johnson, Rudolph C. Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska. Country unknown/Code not available. doi:10.1016/j.hal.2016.03.006.
Knaack, Jennifer S., Porter, Kimberly A., Jacob, Justin T., Sullivan, Kate, Forester, Matthew, Wang, Richard Y., Trainer, Vera L., Morton, Steve, Eckert, Ginny, McGahee, Ernest, Thomas, Jerry, McLaughlin, Joseph, and Johnson, Rudolph C. 2016. "Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska". Country unknown/Code not available. doi:10.1016/j.hal.2016.03.006.
@article{osti_1397895,
title = {Case diagnosis and characterization of suspected paralytic shellfish poisoning in Alaska},
author = {Knaack, Jennifer S. and Porter, Kimberly A. and Jacob, Justin T. and Sullivan, Kate and Forester, Matthew and Wang, Richard Y. and Trainer, Vera L. and Morton, Steve and Eckert, Ginny and McGahee, Ernest and Thomas, Jerry and McLaughlin, Joseph and Johnson, Rudolph C.},
abstractNote = {},
doi = {10.1016/j.hal.2016.03.006},
journal = {Harmful Algae},
number = PB,
volume = 57,
place = {Country unknown/Code not available},
year = 2016,
month = 7
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1016/j.hal.2016.03.006

Save / Share:
  • Lead poisoning of unknown source was diagnosed histologically in 2 rhesus monkeys (Macaca mulatta) by finding acid-fast intranuclear inclusion bodies in the epithelial cells of renal cortical tubules. The presence of lead in the inclusions was determined by scanning electron microscopy/energy dispersive x-ray analysis using sections from paraffin embedded tissues. This observation indicates the usefulness of this technique for the detection and cellular localization of lead in tissues, even from archival material.
  • Shellfish contaminated with paralytic shellfish poisons (PSP) compromise human health. The threat of this contamination results in enormous economic losses in the recreational and commercial exploitation of shellfish resources in the affected areas. Most states deal with the PSP problem either by prohibiting the collection of shellfish during certain time periods or by instituting monitoring programs. The only recognized method of analysis for PSP that is currently and routinely used in monitoring programs is the time-of-death mouse bioassay. Several attempts to develop simple and highly specific biochemical assays for the detection and quantitation of the PSP toxins have been reported.more » More recently, much improved immunoassays have been developed. To evaluate the validity and usefulness of the immunoassay for the determination of PSP toxins, the authors have used extracts of shellfish gathered from Maine and Connecticut to compare the results of the mouse bioassay and HPLC methods with the radioimmunoassay developed previously.« less
  • The use of pulmonary angiography as related to ventilation-perfusion scintigraphy was studied at two teaching hospitals in 600 patients clinically suspected of having pulmonary embolism, using a combined prospective-retrospective approach. Sixty patients underwent angiography, 30 in each institution. A minority of patients in each scintigraphic diagnostic category underwent angiography, but the scintigraphic diagnosis had a major impact on the frequency of requests for angiography. Inconclusive scintigraphy was the principal reason for requesting angiography, although nearly half of patients in whom scintigraphic assessment was indecisive were managed without further diagnostic measures. Few patients in the low-probability and high-probability scintigraphic categories receivedmore » angiography. This study also indicates that a substantial patient selection bias may exist in series that correlate scintigraphic and angiographic results.« less
  • Myophosphorylase deficiency (McArdle disease) is one of the most common causes of exercise intolerance, cramps, and recurrent myoglobinuria. We have described nine mutations in the myophosphorylase gene associated with McArdle disease. One of them, a nonsense mutation (CGA to TGA) at codon 49 (mut-49), was the most frequently observed and was present in at least one allele in 75% of patients. In one patient not harboring any of the previously described mutations, we found a new missense mutation (CTG to CCG), changing an encoded Leu to Pro at codon 396. RFLP analysis showed that the patient was heterozygous for thismore » mutation. Although the myophosphorylase gene on the second allele was only faintly expressed, no mutation could be detected in a PCR-amplified fragment encompassing the reported upstream regulatory sequences. We screened 23 patients with clinically suspected McArdle disease for mut-49 by RFLP analysis of DNA isolated from leukocytes. Ten patients were homozygous and 4 were heterozygous for mut-49. Considering the fact that myophosphorylase deficiency was not demonstrated biochemically in all 23 patients and some of them may not have McArdle disease, the observed frequency of mut-49 (14/23=61%) is similar to the rate (75%) we previously reported in 40 patients. This study provides further evidence for molecular genetic heterogeneity in McArdle disease and confirms the prevalence of mut-49. It also demonstrates that molecular analysis of DNA isolated from leukocytes can be used as a first approach to diagnosis of suspected patients, thus avoiding the need for muscle biopsy.« less